• MA Part D Plan ’24 Rules Mixed Bag

  Published On: 04/07/2023

• Proposed 2024 Rehab Hospital Rates +3.7

  Published On: 04/03/2023

• Gene Therapy Legislation Codifies Best Price(s)

  Published On: 02/25/2023

• CBO: Window Into IRA Rx Price Assumptions

  Published On: 02/21/2023

• PBM Transparency Act Likely to Pass Senate Committee

  Published On: 02/17/2023

• 3 Drug Pilots: Cell & Gene in Medicaid, $2Medicare Generics & Accelerated Approval Pay

  Published On: 02/14/2023

• Biden’s Second State of the Union

  Published On: 02/08/2023

• Drug Negotiation Timeline Released

  Published On: 01/11/2023

• 2024 MA & Part D Rules of the Road

  Published On: 12/15/2022

• Mid-Terms: Healthcare, Oversight, Deficit Reduction

  Published On: 11/17/2022

• Oncology Care Value Based Care Emerges

  Published On: 10/21/2022

• Biden Signs EO Drug Pricing

  Published On: 10/14/2022

• FTC Indicates PBM Law Enforcement & Market Rule

  Published On: 10/10/2022

• 5 Year FDA User Fee Authorization

  Published On: 09/29/2022

• FDA User Fees Likely Pass With Budget Next Week

  Published On: 09/22/2022

• FDA Report Card

  Published On: 09/20/2022

• HHS: BIIB Price Cut May Reduce Part B Premium

  Published On: 01/10/2022

Previous1516